sitagliptin/metformin merck 50 mg/1000 mg film-coated tablets
merck healthcare kgaa frankfurter strasse 250, 64293 darmstadt, germany - sitagliptin, metformin hydrochloride - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 1000 mg - drugs used in diabetes
inegy 10/20 milligram tablets
merck sharp and dohme limited - ezetimibe, simvastatin - tablets - 10/20 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents
inegy 10/80 milligram tablets
merck sharp and dohme limited - ezetimibe, simvastatin - tablets - 10/80 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents
inegy 10/40 milligram tablets
merck sharp and dohme limited - ezetimibe, simvastatin - tablets - 10/40 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents
inegy 10/10 milligram tablets
merck sharp and dohme limited - ezetimibe, simvastatin - tablets - 10/10 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents
atozet 10 /10 milligram film coated tablet
merck sharp and dohme limited - ezetimibe, micronized, atorvastatin, atorvastatin calcium trihydrate - film coated tablet - 10 /10 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents
atozet 10 / 20 milligram film coated tablet
merck sharp and dohme limited - ezetimibe, micronized, atorvastatin calcium trihydrate - film coated tablet - 10 / 20 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents
atozet 10 / 40 milligram film coated tablet
merck sharp and dohme limited - ezetimibe, micronized, atorvastatin, atorvastatin calcium trihydrate - film coated tablet - 10 / 40 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents
atozet 10 / 80 milligram film coated tablet
merck sharp and dohme limited - ezetimibe, micronized, atorvastatin, atorvastatin calcium trihydrate - film coated tablet - 10 / 80 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents
zostavax- zoster vaccine live injection, powder, lyophilized, for suspension sterile diluent- sterile water injection
merck sharp & dohme llc - varicella-zoster virus strain oka/merck live antigen (unii: gpv39zgd8c) (varicella-zoster virus strain oka/merck live antigen - unii:gpv39zgd8c) - varicella-zoster virus strain oka/merck live antigen 19400 [pfu] in 0.65 ml - zostavax® is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older. limitations of use of zostavax: - zostavax is not indicated for the treatment of zoster or postherpetic neuralgia (phn). - zostavax is not indicated for prevention of primary varicella infection (chickenpox). do not administer zostavax to individuals with a history of anaphylactic/anaphylactoid reaction to gelatin, neomycin or any other component of the vaccine. neomycin allergy manifested as contact dermatitis is not a contraindication to receiving this vaccine. {1} do not administer zostavax to individuals who are immunodeficient or immunosuppressed due to disease or therapy, as serious or fatal disseminated vaccine strain varicella-zoster virus disease may occur. causes of immunodeficiency or immunosuppression may include, but are not limited to, primary or acquired immunodeficiency states, aids or other clinical manifestations of infection with human immunodeficiency